{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:29:32Z","timestamp":1745400572336,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11102-021-01154-3","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T09:31:16Z","timestamp":1622799076000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study"],"prefix":"10.1007","volume":"24","author":[{"given":"Kenji","family":"Yoshiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0718-731X","authenticated-orcid":false,"given":"Yasuo","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Shimojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumie","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-07-0098","volume":"157","author":"T Kienitz","year":"2007","unstructured":"Kienitz T, Quinkler M, Strasburger CJ, Ventz M (2007) Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 157:39\u201346. https:\/\/doi.org\/10.1530\/EJE-07-0098","journal-title":"Eur J Endocrinol"},{"key":"1154_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/jc.2012-3362","volume":"98","author":"L Onnestam","year":"2013","unstructured":"Onnestam L, Berinder K, Burman P, Dahlqvist P, Engstrom BE, Wahlberg J, Nystrom HF (2013) National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 98:626\u2013635. https:\/\/doi.org\/10.1210\/jc.2012-3362","journal-title":"J Clin Endocrinol Metab"},{"key":"1154_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3171\/jns.2000.93.2.0194","volume":"93","author":"N Sanno","year":"2000","unstructured":"Sanno N, Teramoto A, Osamura RY (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194\u2013200. https:\/\/doi.org\/10.3171\/jns.2000.93.2.0194","journal-title":"J Neurosurg"},{"key":"1154_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1530\/eje.0.1480433","volume":"148","author":"HV Socin","year":"2003","unstructured":"Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433\u2013442. https:\/\/doi.org\/10.1530\/eje.0.1480433","journal-title":"Eur J Endocrinol"},{"key":"1154_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/JNS\/2008\/109\/7\/0017","volume":"109","author":"MJ Clarke","year":"2008","unstructured":"Clarke MJ, Erickson D, Castro MR, Atkinson JL (2008) Thyroid-stimulating hormone pituitary adenomas. J Neurosurg 109:17\u201322. https:\/\/doi.org\/10.3171\/JNS\/2008\/109\/7\/0017","journal-title":"J Neurosurg"},{"key":"1154_CR6","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3171\/2014.7.JNS1471","volume":"121","author":"S Yamada","year":"2014","unstructured":"Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121:1462\u20131473. https:\/\/doi.org\/10.3171\/2014.7.JNS1471","journal-title":"J Neurosurg"},{"key":"1154_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1023\/a:1012917701756","volume":"54","author":"N Sanno","year":"2001","unstructured":"Sanno N, Teramoto A, Osamura RY (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179\u2013186. https:\/\/doi.org\/10.1023\/a:1012917701756","journal-title":"J Neurooncol"},{"key":"1154_CR8","doi-asserted-by":"publisher","first-page":"e0122388","DOI":"10.1371\/journal.pone.0122388","volume":"10","author":"I Tsymbaliuk","year":"2015","unstructured":"Tsymbaliuk I, Unukovych D, Shvets N, Dinets A (2015) Cardiovascular complications secondary to Graves\u2019 disease: a prospective study from Ukraine. PLoS ONE 10:e0122388. https:\/\/doi.org\/10.1371\/journal.pone.0122388","journal-title":"PLoS ONE"},{"key":"1154_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.wneu.2014.03.031","volume":"82","author":"MA Kirkman","year":"2014","unstructured":"Kirkman MA, Jaunmuktane Z, Brandner S, Khan AA, Powell M, Baldeweg SE (2014) Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence. World Neurosurg 82:1224\u20131231. https:\/\/doi.org\/10.1016\/j.wneu.2014.03.031","journal-title":"World Neurosurg"},{"key":"1154_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00701-017-3105-4","volume":"159","author":"R Rotermund","year":"2017","unstructured":"Rotermund R, Riedel N, Burkhardt T, Matschke J, Schmidt NO, Aberle J, Flitsch J (2017) Surgical treatment and outcome of TSH-producing pituitary adenomas. Acta Neurochir (Wien) 159:1219\u20131226. https:\/\/doi.org\/10.1007\/s00701-017-3105-4","journal-title":"Acta Neurochir (Wien)"},{"key":"1154_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1752-1947-2-67","volume":"2","author":"JT George","year":"2008","unstructured":"George JT, Thow JC, Matthews B, Pye MP, Jayagopal V (2008) Atrial fibrillation associated with a thyroid stimulating hormone-secreting adenoma of the pituitary gland leading to a presentation of acute cardiac decompensation: a case report. J Med Case Rep 2:67. https:\/\/doi.org\/10.1186\/1752-1947-2-67","journal-title":"J Med Case Rep"},{"key":"1154_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","volume":"331","author":"CT Sawin","year":"1994","unstructured":"Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D\u2019Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249\u20131252. https:\/\/doi.org\/10.1056\/NEJM199411103311901","journal-title":"N Engl J Med"},{"key":"1154_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000356954","volume":"127","author":"Q Chen","year":"2014","unstructured":"Chen Q, Yan Y, Zhang L, Cheng K, Liu Y, Zhu W (2014) Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation. Cardiology 127:176\u2013182. https:\/\/doi.org\/10.1159\/000356954","journal-title":"Cardiology"},{"key":"1154_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-11-0299","volume":"165","author":"F Brandt","year":"2011","unstructured":"Brandt F, Green A, Hegedus L, Brix TH (2011) A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol 165:491\u2013497. https:\/\/doi.org\/10.1530\/EJE-11-0299","journal-title":"Eur J Endocrinol"},{"key":"1154_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1210\/jc.2004-1554","volume":"90","author":"M Dorr","year":"2005","unstructured":"Dorr M, Wolff B, Robinson DM, John U, Ludemann J, Meng W, Felix SB, Volzke H (2005) The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab 90:673\u2013677. https:\/\/doi.org\/10.1210\/jc.2004-1554","journal-title":"J Clin Endocrinol Metab"},{"key":"1154_CR16","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725\u20131735. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"1154_CR17","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/j.1538-7836.2010.03993.x","volume":"8","author":"HC Lin","year":"2010","unstructured":"Lin HC, Yang LY, Kang JH (2010) Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5-year follow-up study. J Thromb Haemost 8:2176\u20132181. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03993.x","journal-title":"J Thromb Haemost"},{"key":"1154_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/STROKEAHA.109.577742","volume":"41","author":"JJ Sheu","year":"2010","unstructured":"Sheu JJ, Kang JH, Lin HC, Lin HC (2010) Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study. Stroke 41:961\u2013966. https:\/\/doi.org\/10.1161\/STROKEAHA.109.577742","journal-title":"Stroke"},{"key":"1154_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ejechocard\/jen235","volume":"10","author":"K Fatema","year":"2009","unstructured":"Fatema K, Barnes ME, Bailey KR, Abhayaratna WP, Cha S, Seward JB, Tsang TS (2009) Minimum vs maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr 10:282\u2013286. https:\/\/doi.org\/10.1093\/ejechocard\/jen235","journal-title":"Eur J Echocardiogr"},{"key":"1154_CR20","first-page":"191","volume":"9","author":"DA Patel","year":"2009","unstructured":"Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y (2009) Clinical implications of left atrial enlargement: a review. Ochsner J 9:191\u2013196","journal-title":"Ochsner J"},{"key":"1154_CR21","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1161\/01.cir.96.7.2455","volume":"96","author":"BM Psaty","year":"1997","unstructured":"Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455\u20132461. https:\/\/doi.org\/10.1161\/01.cir.96.7.2455","journal-title":"Circulation"},{"key":"1154_CR22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.cir.89.2.724","volume":"89","author":"SM Vaziri","year":"1994","unstructured":"Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89:724\u2013730. https:\/\/doi.org\/10.1161\/01.cir.89.2.724","journal-title":"The Framingham Heart Study Circulation"},{"key":"1154_CR23","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1161\/01.cir.100.18.1879","volume":"100","author":"SA Chen","year":"1999","unstructured":"Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879\u20131886. https:\/\/doi.org\/10.1161\/01.cir.100.18.1879","journal-title":"Circulation"},{"key":"1154_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/s0735-1097(01)01731-4","volume":"39","author":"YC Chen","year":"2002","unstructured":"Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI (2002) Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 39:366\u2013372. https:\/\/doi.org\/10.1016\/s0735-1097(01)01731-4","journal-title":"J Am Coll Cardiol"},{"key":"1154_CR25","doi-asserted-by":"publisher","first-page":"H1448","DOI":"10.1152\/ajpheart.00828.2004","volume":"289","author":"Y Hu","year":"2005","unstructured":"Hu Y, Jones SV, Dillmann WH (2005) Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. Am J Physiol Heart Circ Physiol 289:H1448-1455. https:\/\/doi.org\/10.1152\/ajpheart.00828.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1154_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrendo.2010.105","volume":"6","author":"B Biondi","year":"2010","unstructured":"Biondi B, Kahaly GJ (2010) Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6:431\u2013443. https:\/\/doi.org\/10.1038\/nrendo.2010.105","journal-title":"Nat Rev Endocrinol"},{"key":"1154_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1210\/rp.59.1.31","volume":"59","author":"S Fazio","year":"2004","unstructured":"Fazio S, Palmieri EA, Lombardi G, Biondi B (2004) Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 59:31\u201350. https:\/\/doi.org\/10.1210\/rp.59.1.31","journal-title":"Recent Prog Horm Res"},{"key":"1154_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1756-6614-2-4","volume":"2","author":"A Bielecka-Dabrowa","year":"2009","unstructured":"Bielecka-Dabrowa A, Mikhailidis DP, Rysz J, Banach M (2009) The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res 2:4. https:\/\/doi.org\/10.1186\/1756-6614-2-4","journal-title":"Thyroid Res"},{"key":"1154_CR29","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1210\/jcem.84.6.5733","volume":"84","author":"B Biondi","year":"1999","unstructured":"Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, Sacca L (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064\u20132067. https:\/\/doi.org\/10.1210\/jcem.84.6.5733","journal-title":"J Clin Endocrinol Metab"},{"key":"1154_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1210\/jcem.87.3.8302","volume":"87","author":"B Biondi","year":"2002","unstructured":"Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968\u2013974. https:\/\/doi.org\/10.1210\/jcem.87.3.8302","journal-title":"J Clin Endocrinol Metab"},{"key":"1154_CR31","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1210\/jcem.80.7.7608283","volume":"80","author":"S Fazio","year":"1995","unstructured":"Fazio S, Biondi B, Carella C, Sabatini D, Cittadini A, Panza N, Lombardi G, Sacca L (1995) Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade. J Clin Endocrinol Metab 80:2222\u20132226. https:\/\/doi.org\/10.1210\/jcem.80.7.7608283","journal-title":"J Clin Endocrinol Metab"},{"key":"1154_CR32","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1172\/JCI46315","volume":"121","author":"R Wakili","year":"2011","unstructured":"Wakili R, Voigt N, Kaab S, Dobrev D, Nattel S (2011) Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 121:2955\u20132968. https:\/\/doi.org\/10.1172\/JCI46315","journal-title":"J Clin Invest"},{"key":"1154_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/physrev.00014.2006","volume":"87","author":"S Nattel","year":"2007","unstructured":"Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425\u2013456. https:\/\/doi.org\/10.1152\/physrev.00014.2006","journal-title":"Physiol Rev"},{"key":"1154_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 1:62\u201373. https:\/\/doi.org\/10.1161\/CIRCEP.107.754564","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1154_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd3682","volume":"11","author":"D Dobrev","year":"2012","unstructured":"Dobrev D, Carlsson L, Nattel S (2012) Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discov 11:275\u2013291. https:\/\/doi.org\/10.1038\/nrd3682","journal-title":"Nat Rev Drug Discov"},{"key":"1154_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","volume":"52","author":"FG Amlashi","year":"2016","unstructured":"Amlashi FG, Tritos NA (2016) Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine 52:427\u2013440. https:\/\/doi.org\/10.1007\/s12020-016-0863-3","journal-title":"Endocrine"},{"key":"1154_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.beem.2009.05.006","volume":"23","author":"P Beck-Peccoz","year":"2009","unstructured":"Beck-Peccoz P, Persani L, Mannavola D, Campi I (2009) Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab 23:597\u2013606. https:\/\/doi.org\/10.1016\/j.beem.2009.05.006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1154_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11102-011-0318-z","volume":"15","author":"A Colao","year":"2012","unstructured":"Colao A (2012) Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Pituitary 15:50\u201358. https:\/\/doi.org\/10.1007\/s11102-011-0318-z","journal-title":"Pituitary"},{"key":"1154_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2265.2008.03292.x","volume":"69","author":"A Colao","year":"2008","unstructured":"Colao A (2008) The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf) 69:347\u2013358. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03292.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1154_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0167-5273(81)90047-4","volume":"1","author":"JC Forfar","year":"1981","unstructured":"Forfar JC, Feek CM, Miller HC, Toft AD (1981) Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy. Int J Cardiol 1:43\u201348. https:\/\/doi.org\/10.1016\/0167-5273(81)90047-4","journal-title":"Int J Cardiol"},{"key":"1154_CR41","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","volume":"72","author":"HK Nakazawa","year":"1982","unstructured":"Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K (1982) Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 72:903\u2013906. https:\/\/doi.org\/10.1016\/0002-9343(82)90850-6","journal-title":"Am J Med"},{"key":"1154_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/105072502760143863","volume":"12","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H (2002) Hyperthyroidism and the management of atrial fibrillation. Thyroid 12:489\u2013493. https:\/\/doi.org\/10.1089\/105072502760143863","journal-title":"Thyroid"},{"key":"1154_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/europace\/eux013","volume":"20","author":"A Njoku","year":"2018","unstructured":"Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, Dominic P (2018) Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 20:33\u201342. https:\/\/doi.org\/10.1093\/europace\/eux013","journal-title":"Europace"},{"key":"1154_CR44","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/hrt.2005.082594","volume":"92","author":"H Okura","year":"2006","unstructured":"Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Taguchi H, Toda I, Yoshikawa J, Yoshida K (2006) Tissue Doppler-derived index of left ventricular filling pressure, E\/E\u2019, predicts survival of patients with non-valvular atrial fibrillation. Heart 92:1248\u20131252. https:\/\/doi.org\/10.1136\/hrt.2005.082594","journal-title":"Heart"},{"key":"1154_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000351007","volume":"2","author":"P Beck-Peccoz","year":"2013","unstructured":"Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL (2013) 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2:76\u201382. https:\/\/doi.org\/10.1159\/000351007","journal-title":"Eur Thyroid J"},{"key":"1154_CR46","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1210\/jcem.81.8.8768879","volume":"81","author":"M Losa","year":"1996","unstructured":"Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P (1996) Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084\u20133090. https:\/\/doi.org\/10.1210\/jcem.81.8.8768879","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-021-01154-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:54:29Z","timestamp":1630713269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-021-01154-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s11102-021-01154-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"10 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This cohort study was approved by the ethics committee at Kanazawa University [No. 2019\u2013299(3310)] and Kanazawa Medical University [No. I 621].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The document about opt-out was made public on the website of our laboratory to guarantee the opportunity for research subjects and others to refuse to participate in the research, and at the same time, a contact point (contact information) was clearly indicated to accept the refusal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}}]}}